Detection of platinum-DNA adducts by 32P-postlabelling. - Wikidata - wikimedia - TriplyDB

Detection of platinum-DNA adducts by 32P-postlabelling.

Detection of platinum-DNA adducts by 32P-postlabelling.

http://www.wikidata.org/entity/Q34746244

about

A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance.Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.Cross-linking to an interrupted polypurine sequence with a platinum-modified triplex-forming oligonucleotide.Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA.Determination of bulky DNA adducts in biomonitoring of carcinogenic chemical exposures: features and comparison of current techniques.3D-DIP-Chip: a microarray-based method to measure genomic DNA damage.Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.

P2860

Q35131936-7A9B1450-15E4-41D2-A5AE-0D5C9696BBD1 Q36817080-666E9DAC-47E8-45F6-908E-B699768F762D Q37309473-7B575532-A40A-4A81-92B4-6FC35E8A0F2B Q37314686-05C0A82E-25F1-4BFA-A369-B2B8BD922480 Q37484883-C2C100EC-1E09-4BBE-A507-278AB4C01425 Q38125237-87613FF9-3AFE-4E18-8C4D-EB7DFE572659 Q43114888-75B3A919-5E64-480B-BB26-E34D7E3D6894 Q43157204-38B98056-0DB2-4259-948B-1E28FB8BF084

P2860

Detection of platinum-DNA adducts by 32P-postlabelling.

http://www.wikidata.org/entity/Q34746244

description

1995 nî lūn-bûn

@nan

1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Detection of platinum-DNA adducts by 32P-postlabelling.

@ast

Detection of platinum-DNA adducts by 32P-postlabelling.

@en

Detection of platinum-DNA adducts by 32P-postlabelling.

@nl

type

label

Detection of platinum-DNA adducts by 32P-postlabelling.

@ast

Detection of platinum-DNA adducts by 32P-postlabelling.

@en

Detection of platinum-DNA adducts by 32P-postlabelling.

@nl

prefLabel

Detection of platinum-DNA adducts by 32P-postlabelling.

@ast

Detection of platinum-DNA adducts by 32P-postlabelling.

@en

Detection of platinum-DNA adducts by 32P-postlabelling.

@nl

P1433

Q34746244-8DA1D45B-AB36-430D-966F-26EA7C4FDC0F

P1476

Q34746244-7440E000-1099-4E25-A3EF-A9D143A825D2

P2093

Q34746244-470CBB64-39C3-4872-8A50-296903F77764

Q34746244-ECE55424-D1CD-425A-A5B9-EB0AAE256A6C

P2860

Q34746244-25A867C1-0536-4EC3-BC85-F398148096F6

Q34746244-2F185184-98D2-4A51-91CE-0130B7DDA7EB

Q34746244-527013A9-4DDF-4D60-BF0F-9A612416175F

Q34746244-5D0DBD1F-6FAA-4BC4-81BF-D5692D5F1C79

Q34746244-62549758-7ECE-4C75-AC36-07630CAB5AD7

Q34746244-65E2111D-9EEF-4B74-99C5-42585B6DB93F

Q34746244-6C73420D-DF01-4A07-A130-3BC25E9353CB

Q34746244-7706C52D-00D0-446B-AF25-EA00833D36ED

Q34746244-920FE286-304D-45B9-8F64-84484597F7F2

Q34746244-9339234C-2728-4E2C-B4C9-5D538206C293

P304

Q34746244-95BC56FE-7B27-4017-9AD9-82523396E0A7

P31

Q34746244-D05D729E-EC48-41BC-930F-22ACD4C544BE

P356

Q34746244-3DE2CC4C-A490-44F3-8EE4-17149EDDADCC

P407

Q34746244-E05A7F27-547C-4A09-A983-202D2DAD5157

P433

Q34746244-DFEE9254-021D-4BD2-96E2-2FDBC8E3F6F7

P478

Q34746244-ED911D52-AFA7-4136-9052-07AEEC09233D

P577

Q34746244-37977890-8677-413E-B030-DFF190A6FA79

P5875

Q34746244-6F7CEAC2-84DE-4D2E-82EF-6328FE7149C3

P698

Q34746244-94CE0E73-870D-46C0-88C9-D2504E1B8DEA

P932

Q34746244-C44207D3-67D1-484D-9393-2513267C721E

P356

P1433

Nucleic Acids Research

P1476

Detection of platinum-DNA adducts by 32P-postlabelling.

@en

P2093

Blommaert FA

http://www.w3.org/2001/XMLSchema#string

Saris CP

http://www.w3.org/2001/XMLSchema#string

P2860

Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides

The current status of new platinum analogs.

Platinum drug-DNA interactions in human tissues measured by cisplatin-DNA enzyme-linked immunosorbent assay and atomic absorbance spectroscopy.

Polyclonal antibodies to quantitate cis-diamminedichloroplatinum(II)--DNA adducts in cancer patients and animal models.

Apoptosis induced by anticancer drugs.

32P-labeling test for DNA damage.

Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA.

DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells.

Activation of programmed cell death by anticancer agents: cisplatin as a model system.

Resistance to cisplatin and analogues: mechanisms and potential clinical implications.

P304

1300-1306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/23.8.1300

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

1995-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

238809316

http://www.w3.org/2001/XMLSchema#string

P698

7753620

http://www.w3.org/2001/XMLSchema#string

P932

306853

http://www.w3.org/2001/XMLSchema#string